Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3313964
Max Phase: Preclinical
Molecular Formula: C25H27FN4O10
Molecular Weight: 562.51
Molecule Type: Small molecule
Associated Items:
ID: ALA3313964
Max Phase: Preclinical
Molecular Formula: C25H27FN4O10
Molecular Weight: 562.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)CC(O)(CC(=O)NCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1)C(=O)O
Standard InChI: InChI=1S/C25H27FN4O10/c26-16-7-14-17(30(13-1-2-13)12-15(22(14)35)23(36)37)8-18(16)28-3-5-29(6-4-28)20(32)11-27-19(31)9-25(40,24(38)39)10-21(33)34/h7-8,12-13,40H,1-6,9-11H2,(H,27,31)(H,33,34)(H,36,37)(H,38,39)
Standard InChI Key: VYUWJZXPMMZVKJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 562.51 | Molecular Weight (Monoisotopic): 562.1711 | AlogP: -0.38 | #Rotatable Bonds: 10 |
Polar Surface Area: 206.78 | Molecular Species: ACID | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.13 | CX Basic pKa: | CX LogP: -1.04 | CX LogD: -8.38 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.25 | Np Likeness Score: -0.61 |
1. Milner SJ, Snelling AM, Kerr KG, Abd-El-Aziz A, Thomas GH, Hubbard RE, Routledge A, Duhme-Klair AK.. (2014) Probing linker design in citric acid-ciprofloxacin conjugates., 22 (16): [PMID:24794750] [10.1016/j.bmc.2014.04.009] |
Source(1):